MeiraGTx Holdings plc financial data

Symbol
MGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
450 East 29 Th Street, 14 Th Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 243 % +30.7%
Debt-to-equity 213 % +26.6%
Return On Equity -162 % -114%
Return On Assets -51.6 % -83.2%
Operating Margin -493 % +49.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.9M shares +22.8%
Common Stock, Shares, Outstanding 78.4M shares +23.3%
Entity Public Float 272M USD +4.76%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 69.8M shares +23.6%
Weighted Average Number of Shares Outstanding, Diluted 69.8M shares +23.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 33.3M USD +137%
Revenue from Contract with Customer, Excluding Assessed Tax 6.69M USD -84.2%
Research and Development Expense 119M USD +15.1%
Selling and Marketing Expense 12M USD
General and Administrative Expense 54.2M USD +14.6%
Operating Income (Loss) -164M USD -19.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -148M USD -75.9%
Earnings Per Share, Basic -2.12 USD/shares -42.3%
Earnings Per Share, Diluted -2.12 USD/shares -42.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 104M USD -20%
Accounts Receivable, after Allowance for Credit Loss, Current 707K USD -93%
Inventory, Net 385K USD
Other Assets, Current 2.02M USD +98.6%
Assets, Current 124M USD -22.6%
Property, Plant and Equipment, Net 103M USD -11.2%
Operating Lease, Right-of-Use Asset 10.6M USD -33.5%
Intangible Assets, Net (Excluding Goodwill) 821K USD -26.6%
Other Assets, Noncurrent 1M USD -47.7%
Assets 270M USD -17.4%
Accounts Payable, Current 23.6M USD +47%
Accrued Liabilities, Current 27.4M USD -35.7%
Liabilities, Current 60.8M USD -9.39%
Deferred Income Tax Liabilities, Net 184K USD +7.6%
Operating Lease, Liability, Noncurrent 7.52M USD -41.9%
Liabilities 202M USD +7.08%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.72M USD -159%
Retained Earnings (Accumulated Deficit) -702M USD -26.7%
Stockholders' Equity Attributable to Parent 67.8M USD -50.9%
Liabilities and Equity 270M USD -17.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.7M USD +1.74%
Net Cash Provided by (Used in) Financing Activities -1.27M USD -3.17%
Net Cash Provided by (Used in) Investing Activities 27.3M USD
Common Stock, Shares Authorized 1.29B shares 0%
Common Stock, Shares, Issued 78.4M shares +23.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 106M USD -19.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.95M USD +87.9%
Deferred Tax Assets, Valuation Allowance 149M USD +18.7%
Deferred Tax Assets, Gross 155M USD +19.1%
Operating Lease, Liability 11.6M USD -32.5%
Payments to Acquire Property, Plant, and Equipment 1.68M USD -80.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -150M USD -64%
Lessee, Operating Lease, Liability, to be Paid 13.2M USD -35.1%
Property, Plant and Equipment, Gross 145M USD -2.71%
Operating Lease, Liability, Current 4.05M USD -3.34%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.08M USD -8.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.94M USD -11.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.65M USD -49.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.43M USD -74.6%
Deferred Tax Assets, Operating Loss Carryforwards 85.3M USD +20.7%
Unrecognized Tax Benefits 2.25M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.24M USD -23.9%
Operating Lease, Payments 5.41M USD -4.49%
Additional Paid in Capital 774M USD +11.5%
Depreciation, Depletion and Amortization 3.28M USD +5.92%
Share-based Payment Arrangement, Expense 25.2M USD -9.11%
Interest Expense 13.3M USD +0.2%